Vertex Pharmaceuticals
VRTX
#153
Rank
A$175.13 B
Marketcap
$680.08
Share price
1.21%
Change (1 day)
2.42%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2024 (TTM): A$0.40 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are A$10.62 Billion. In 2023 the company made an earning of A$7.12 Billion, an increase over its 2022 earnings that were of A$6.90 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.40 B-94.29%
2023 A$7.12 B3.19%
2022 A$6.90 B53.56%
2021 A$4.49 B-12.06%
2020 A$5.11 B118.45%
2019 A$2.34 B120.64%
2018 A$1.06 B1473.64%
2017 A$67.46 M197.6%
2016 A$22.66 M-102.97%
2015 -A$0.77 Billion-28.46%
2014 -A$1.07 Billion-51.5%
2013 -A$2.2 Billion-30584.68%
2012 A$7.21 M-95.47%
2011 A$0.15 B
2009 -A$0.96 Billion
2007 -A$0.67 Billion83.1%
2006 -A$0.37 Billion59.02%
2005 -A$0.23 Billion3.28%
2004 -A$0.23 Billion-38.16%
2003 -A$0.36 Billion
2000 -A$61.31 Million-20.38%
1999 -A$77 Million31.62%
1998 -A$58.5 Million91.05%
1997 -A$30.62 Million-36.24%
1996 -A$48.03 Million12.45%
1995 -A$42.71 Million27.4%
1994 -A$33.53 Million-1833.33%
1993 A$1.93 M-112.12%
1992 -A$15.96 Million175%
1991 -A$5.81 Million-12.2%
1990 -A$6.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$0.28 B-40.94%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.59 B 2,315.10%๐Ÿ‡บ๐Ÿ‡ธ USA
A$24.12 B 4,924.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$11.09 Billion-2,408.72%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.64 B 6,072.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.18 Billion-135.86%๐Ÿ‡บ๐Ÿ‡ธ USA